This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Social disorders starting during childhood or adolescence
KRA_PSY_CHILDSOC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
309 |
4. Check minimum number of eventsNone |
309 |
5. Include endpointsNone |
309 |
6. Filter based on genotype QC (FinnGen only) |
309 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes functionum socialium specialiter in pueritia incipientes
Similar endpoints
↥List of similar endpoints to
Social disorders starting during childhood or adolescence
based on the number of shared cases.
Similar with more cases:
- Social disorders starting during childhood or adolecense, excluding more controls
- Emotional disorders and disorders of social functioning with onset specific to childhood
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 173 | 136 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 11.27 | 12.22 | 10.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 286
- Matched controls
- 2859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F94.0
ICD-10 Finland
Elective mutism
+∞
83.5
76
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
+∞
75.4
69
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
67.4
62
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
56.1
52
*
3138X
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[MUU MÄÄRITTELTY EMOTIONAALISENA OIREENA ILM. HÄIRIÖ]
+∞
41.7
39
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.3
32.8
124
359
N05AH04
ATC
quetiapine; oral
5.0
30.2
119
354
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.7
29.5
74
124
N05AH03
ATC
olanzapine; systemic
7.0
26.7
71
128
N05AX08
ATC
risperidone; systemic
7.2
26.1
68
119
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.3
22.9
46
52
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
25.6
21.8
30
13
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
25.6
21.8
30
13
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.8
20.2
53
92
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.3
20.0
56
106
N05AX12
ATC
aripiprazole; systemic
6.0
18.9
55
109
N03AG01
ATC
valproic acid; systemic, rectal
6.7
18.6
49
85
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.6
17.9
43
65
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.8
17.9
88
299
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.7
17.8
39
51
R5599
NOMESCO Finland
Other rehabilitation service
12.7
17.5
31
27
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.0
16.4
56
133
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
28.2
15.8
21
8
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.5
15.3
58
153
N05AF03
ATC
chlorprothixene; systemic
12.9
14.9
26
22
F94.2
ICD-10 Finland
Disinhibited attachment disorder of childhood
+∞
14.7
14
*
N05BA01
ATC
diazepam; systemic, rectal
4.6
14.7
54
138
N06AB03
ATC
fluoxetine; oral
4.2
14.2
58
164
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.9
14.0
48
114
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
7.0
13.7
34
54
N05AA02
ATC
levomepromazine; systemic
9.3
13.6
28
33
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.6
13.5
35
59
N06AX16
ATC
venlafaxine; oral
3.7
13.4
64
207
F92.0
ICD-10 Finland
Depressive conduct disorder
13.1
13.4
23
19
N05AH02
ATC
clozapine; systemic
7.4
13.1
31
46
Z61.8
ICD-10 Finland
Other negative life events in childhood
20.2
13.1
19
10
F84.5
ICD-10 Finland
Asperger syndrome
10.4
13.0
25
26
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.3
12.9
40
85
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.6
12.9
33
55
N05CF01
ATC
zopiclone; oral
3.6
12.4
60
196
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
10.0
12.3
24
26
F20.9
ICD-10 Finland
Schizophrenia, unspecified
10.8
12.2
23
23
N05BA04
ATC
oxazepam; oral
3.1
12.2
75
292
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.2
11.9
37
79
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.7
11.8
27
38
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
11.8
11.7
21
19
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
15.9
11.5
18
12
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.4
11.3
61
214
N06BA04
ATC
methylphenidate; oral
4.5
11.3
41
103
IGV01
NOMESCO Finland
Psychiatric network contact
7.0
11.1
27
42
N05BE01
ATC
buspirone; oral
12.6
11.0
19
16
N03AX09
ATC
lamotrigine; oral
4.7
11.0
38
91
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.2
10.7
41
109
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
10.5
58
208
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
10.5
69
279
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
24.4
10.3
14
6
N06AB04
ATC
citalopram; systemic
3.3
10.1
55
193
IGP01
NOMESCO Finland
Psychiatric family contact
6.1
10.1
27
48
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
9.5
45
144
3138C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[LAPSUUSIÄN RAJATILAHÄIRIÖ]
+∞
9.4
9
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
11.2
9.4
17
16
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.0
9.3
25
45
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.0
9.3
25
45
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.9
9.3
30
67
P72
ICPC
Schizophrenia
9.5
9.2
18
20
F88
ICD-10 Finland
Other disorders of psychological development
16.3
9.1
14
9
N06AB06
ATC
sertraline; oral
3.1
9.1
54
201
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.5
8.9
31
75
N06AX11
ATC
mirtazapine; oral
2.5
8.8
82
402
Z61.1
ICD-10 Finland
Removal from home in childhood
51.6
8.7
10
*
F83
ICD-10 Finland
Mixed specific developmental disorders
5.7
8.7
24
45
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
8.6
41
132
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
9.0
8.4
17
20
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
8.4
36
106
3132C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Sensitivity, shyness and social withdrawal disorder
+∞
8.4
8
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
+∞
8.4
8
*
N06AB10
ATC
escitalopram; oral
2.4
8.4
81
402
F80.2
ICD-10 Finland
Receptive language disorder
6.9
8.3
20
31
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.9
8.3
20
31
F80.1
ICD-10 Finland
Expressive language disorder
6.4
8.3
21
35
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.8
8.3
27
61
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.9
8.2
26
57
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
8.1
50
193
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
22.8
8.1
11
5
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
8.8
7.9
16
19
P29
ICPC
Psychological sympt/compl other
2.9
7.7
48
186
F84.8
ICD-10 Finland
Other pervasive developmental disorders
19.0
7.7
11
6
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
7.5
7.6
17
24
N03AE01
ATC
clonazepam; systemic
6.3
7.5
19
32
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
8.0
7.5
16
21
N05AN01
ATC
lithium; oral
7.2
7.4
17
25
N05AB03
ATC
perphenazine; systemic, rectal
7.2
7.4
17
25
P74
ICPC
Anxiety disorder/anxiety state
3.4
7.4
35
112
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.7
7.4
31
90
IEV99
NOMESCO Finland
Other psychiatric network intervention
6.5
7.4
18
29
R4140
NOMESCO Finland
Psychotherapy
9.7
7.4
14
15
IEP03
NOMESCO Finland
Focused parental counselling
7.6
7.3
16
22
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.6
7.3
32
97
R4120
NOMESCO Finland
Occupational therapy
4.1
7.2
27
71
RS214
NOMESCO Finland
NA
20.6
7.2
10
5
S29
ICPC
Skin symptom/complaint other
2.5
7.1
58
262
K02.1
ICD-10 Finland
Caries of dentine
2.0
7.0
199
1522
N05BA06
ATC
lorazepam; systemic, sublingual
5.3
6.9
20
40
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.7
6.9
13
14
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
41.1
6.8
8
*
N05AA01
ATC
chlorpromazine; systemic, rectal
41.1
6.8
8
*
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.8
6.7
21
46
Z71.8
ICD-10 Finland
Other specified counselling
2.1
6.7
92
531
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.7
6.6
28
82
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
6.4
33
114
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
6.3
43
174
F89
ICD-10 Finland
Unspecified disorder of psychological development
18.5
6.3
9
5
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.5
6.2
15
24
C07AB07
ATC
bisoprolol; oral
2.6
6.2
46
198
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.0
6.2
35
127
N06AB05
ATC
paroxetine; oral
4.0
6.1
23
61
N05CD07
ATC
temazepam; oral
7.0
6.1
14
21
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
10.3
6.1
11
11
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
10.3
6.1
11
11
P99
ICPC
Psychological disorders other
4.3
6.0
21
52
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
6.0
26
78
F82
ICD-10 Finland
Specific developmental disorder of motor function
5.0
6.0
18
38
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
34
8.26
18.97
21.8
22.7
1409.3
1611.4
nmol/l
0.28
26
34
138
751
2.51
13.85
4.7
3.2
28.3
31.5
u/l
0.85
132
706
141
781
2.48
13.55
8.4
8.6
1.2
1.2
mmol/l
0.05
132
725
110
556
2.52
12.73
1.9
1.5
94.3
97.6
pmol/l
0.39
59
291
146
859
2.33
11.83
8.6
8.7
1.2
1.2
mmol/l
0.26
129
753
91
436
2.54
11.66
2.4
1.6
1.5
1.4
%
2.53
83
402
122
685
2.29
10.83
6.3
5.8
37.8
38.4
g/l
0.47
111
642
51
187
3.07
10.83
1.7
1.5
1054.0
1021.7
nmol/l
0.10
45
148
82
389
2.51
10.62
2.2
2.3
162.5
394.8
u/l
0.74
77
372
33
99
3.61
9.61
1.5
1.3
—
—
—
0
0
68
314
2.49
9.22
1.6
1.3
15.9
19.1
nmol/l
1.51
63
276
101
565
2.17
8.72
4.2
3.2
0.2
0.2
e6/l
0.01
72
417
204
1484
2.10
8.63
8.8
5.6
85.4
84.6
u/l
0.08
188
1386
137
865
2.05
8.55
7.5
5.6
9.8
10.9
umol/l
0.82
123
810
240
1865
2.28
8.48
4.8
3.8
14.1
14.5
pmol/l
2.18
226
1705
112
673
2.04
7.88
4.2
3.3
—
—
—
0
0
67
329
2.32
7.85
3.2
2.9
0.8
0.5
e6/l
0.78
36
167
168
1179
1.93
7.41
6.6
5.1
6.1
6.1
mmol/l
0.04
156
1042
95
553
2.04
7.19
3.1
2.5
2.4
2.4
mmol/l
0.10
86
503
207
1568
1.97
7.16
4.6
3.3
36.4
36.5
mmol/mol
0.04
202
1487
60
294
2.29
7.02
10.6
8.8
1.2
1.2
mmol/l
0.16
54
284
55
262
2.34
6.86
5.8
8.9
1.2
1.2
mmol/l
0.00
47
203
194
1453
1.90
6.76
18.5
9.1
3.8
3.8
e9/l
0.08
170
1255
133
884
1.89
6.74
3.7
2.8
67.8
68.1
nmol/l
0.04
124
825
38
153
2.69
6.74
6.7
9.5
1.2
1.3
mmol/l
0.28
38
137
63
325
2.18
6.49
3.3
3.0
5.6
3.1
e6/l
0.81
32
165
231
1856
1.97
6.23
4.7
2.5
5.8
5.5
mmol/l
2.72
219
1708
22
69
3.36
5.99
1.4
1.6
—
—
—
0
0
255
2145
2.08
5.71
5.8
4.2
1.9
1.8
mu/l
0.37
245
2020
87
539
1.85
5.28
4.3
2.6
51.8
54.5
u/l
0.33
77
495
203
1607
1.77
5.25
5.3
3.2
47.5
30.8
u/l
1.64
189
1546
14
35
4.14
5.22
1.3
1.5
—
—
—
0
0
50
258
2.12
5.10
5.4
4.4
5.2
8.6
umol/l
0.95
35
204
280
2486
2.35
4.76
12.1
7.4
31.5
28.0
u/l
0.86
272
2398
40
200
2.15
4.42
2.9
2.7
29.0
30.3
u/l
0.12
35
170
225
1882
1.72
4.29
14.4
7.1
107.5
106.1
ml/min/173m2
0.37
175
1406
11
29
3.90
3.84
5.7
2.0
17.2
18.0
%
—
5
15
46
256
1.94
3.81
2.1
1.8
—
—
—
0
0
15
50
3.10
3.74
3.6
5.6
62.7
49.0
%
1.06
15
50
46
259
1.91
3.68
1.7
1.5
450.4
28511075.4
pmol/l
0.50
41
235
19
74
2.67
3.62
6.2
11.1
0.7
0.7
%
0.11
19
74
227
1943
1.63
3.55
4.0
2.7
2.8
2.8
mmol/l
0.46
219
1834
19
75
2.63
3.53
6.3
11.0
2.7
1.4
%
1.32
19
75
19
76
2.60
3.45
6.4
10.9
90.1
94.8
%
0.74
19
76
215
1826
1.58
3.38
3.5
2.5
1.4
1.2
mmol/l
2.72
202
1728
42
241
1.86
3.18
8.7
11.6
24.5
25.0
mmol/l
0.56
42
241
271
2456
1.84
3.15
15.9
9.3
21.1
20.9
mg/l
0.03
213
1764
77
528
1.61
3.10
3.5
2.5
1.0
1.0
kg/l
0.81
11
71
80
554
1.60
3.09
2.6
2.7
2.8
2.6
mg/l
0.72
72
479
21
94
2.32
3.04
3.3
8.8
1.1
1.2
inr
—
7
24
66
444
1.62
2.86
2.2
2.8
0.7
1.1
mg/l
0.85
44
292
45
276
1.74
2.75
4.7
2.7
47.2
1554.3
ng/l
1.43
17
122
8
19
4.29
2.69
1.5
1.5
—
—
—
0
0
220
1923
1.50
2.64
3.7
2.6
1.3
1.4
mmol/l
4.41
209
1823
32
180
1.87
2.59
1.7
1.5
—
—
—
0
0
18
82
2.27
2.52
2.0
1.6
—
—
—
0
0
64
442
1.56
2.47
3.6
2.3
15.4
18.3
ng/l
0.19
33
168
27
146
1.93
2.46
1.7
1.8
—
—
—
0
0
32
184
1.82
2.43
1.8
1.6
—
—
—
0
0
16
71
2.32
2.38
7.2
11.3
24.6
23.8
mmol/l
0.40
16
66
220
1941
1.46
2.37
3.9
2.7
4.5
4.5
mmol/l
0.19
213
1842
42
267
1.66
2.27
4.5
4.9
21.6
17.7
mg/mmol
0.10
25
196
7
18
3.95
2.26
1.3
1.0
—
—
—
0
0
7
18
3.95
2.26
1.3
1.5
—
—
—
0
0
7
18
3.95
2.26
1.6
1.9
11.1
9.7
umol/l
—
7
18
7
18
3.95
2.26
2.6
4.8
22.0
20.8
umol/l
—
7
18
7
19
3.74
2.16
1.3
1.1
—
—
—
0
0
33
200
1.73
2.12
1.9
1.9
5.2
7.0
u/l
0.97
26
151
27
154
1.83
2.12
4.6
2.2
—
—
—
0
0
8
25
3.26
2.11
1.1
1.1
—
—
—
0
0
20
103
2.01
2.10
2.2
2.8
75.7
95.9
ml/min/173m2
—
7
37
35
218
1.68
2.05
2.8
2.2
2.4
2.4
mmol/l
0.10
29
188
6
15
4.06
2.05
1.0
1.0
2070.2
1556.5
miu/ml
—
6
15
36
227
1.66
2.02
2.8
1.9
—
—
—
0
0
28
167
1.74
1.91
1.4
1.4
—
—
—
0
0
46
313
1.55
1.90
3.0
2.7
20228.3
4002.1
u/l
0.72
15
135
38
253
1.57
1.73
2.9
2.2
317.8
384.8
nmol/l
1.31
33
234
16
83
1.98
1.68
1.9
1.5
—
—
—
0
0
40
273
1.53
1.64
3.2
4.0
29.3
30.3
s
0.92
40
266
39
265
1.54
1.64
1.1
1.0
—
—
—
0
0
111
914
1.33
1.61
1.5
1.5
0.4
2.4
u/ml
2.53
19
203
177
1559
1.32
1.59
4.6
3.7
9.5
7.2
mm/h
1.44
172
1452
7
26
2.73
1.59
1.3
1.4
—
—
—
0
0
18
100
1.85
1.56
1.4
1.5
—
—
—
0
0
28
178
1.63
1.55
2.0
1.9
4.7
10.9
iu/l
3.33
22
129
7
27
2.63
1.52
1.7
1.3
737.3
308.8
pmol/l
—
7
19
20
117
1.76
1.49
2.0
1.7
—
—
—
0
0
15
80
1.92
1.47
1.9
2.0
36.9
39.4
u/l
0.32
15
75
145
1252
1.30
1.47
3.7
3.1
75.2
64.0
ug/l
0.43
140
1167
7
29
2.45
1.40
4.0
1.7
—
—
—
0
0
247
2303
1.36
1.37
25.3
12.2
13.4
13.1
%
1.21
241
2267
5
18
2.81
1.29
1.4
3.1
—
—
—
0
0
5
18
2.81
1.29
1.4
3.1
—
—
—
0
0
5
18
2.81
1.29
1.4
1.5
—
—
—
0
0
76
612
1.32
1.26
2.8
2.1
—
—
—
0
0
109
924
1.28
1.23
2.7
2.3
—
—
—
0
0
5
19
2.66
1.22
1.0
1.0
—
—
—
0
0
24
157
1.57
1.21
1.7
2.2
—
17.0
—
0
12
126
1091
1.26
1.19
4.4
2.8
0.0
0.0
estimate
0.00
28
230
19
294
0.62
1.19
1.2
1.3
—
—
—
0
0
20
128
1.60
1.11
1.3
1.6
—
—
—
0
0
33
237
1.44
1.10
1.6
1.2
—
—
—
0
0
29
203
1.47
1.10
3.2
3.7
1239.9
420.4
ng/l
0.39
22
154
8
41
1.98
1.09
1.4
1.8
—
—
—
0
0
5
21
2.40
1.09
1.4
1.4
—
—
—
0
0
114
986
1.25
1.07
4.7
4.1
—
—
—
0
0
7
33
2.15
1.06
1.1
1.1
—
—
—
0
0
5
22
2.29
1.04
1.0
1.5
—
—
—
0
0
25
172
1.49
1.03
5.4
3.5
4.7
5.0
pmol/l
0.80
20
159
9
48
1.90
1.01
1.6
1.7
—
—
—
0
0
7
35
2.02
1.00
1.4
1.2
—
—
—
0
0
7
37
1.91
0.94
1.0
1.3
—
—
—
0
0
19
126
1.54
0.93
1.3
1.6
197.0
185.9
u/ml
0.11
12
69
6
28
2.16
0.92
1.0
1.0
—
—
—
0
0
21
144
1.49
0.90
1.5
1.4
—
—
—
0
0
6
29
2.09
0.90
1.2
1.9
—
—
—
0
0
6
29
2.09
0.90
1.5
1.9
—
—
—
0
0
243
2543
0.79
0.89
4.5
4.1
—
—
—
0
0
123
1091
1.21
0.88
6.3
4.0
0.0
0.0
estimate
0.00
28
244
114
1004
1.21
0.88
3.1
2.4
—
—
—
0
0
42
328
1.32
0.88
1.5
1.2
9.5
13.3
iu/ml
—
8
83
30
222
1.39
0.87
3.1
5.8
0.4
1.3
mmol/l
0.79
20
159
8
44
1.84
0.86
3.4
4.6
7.6
4.9
u/ml
—
8
39
13
80
1.65
0.86
1.2
1.1
—
—
—
0
0
124
1104
1.21
0.85
4.5
2.9
0.0
0.0
estimate
0.00
28
233
6
31
1.95
0.85
1.2
1.7
—
—
—
0
0
11
65
1.72
0.83
2.5
2.2
—
—
—
0
0
35
446
0.76
0.80
1.7
1.5
—
—
—
0
0
13
198
0.64
0.80
1.9
1.6
—
—
—
0
0
61
508
1.25
0.79
2.7
2.0
—
—
—
0
0
6
33
1.83
0.79
1.3
2.5
—
—
—
0
0
32
244
1.35
0.79
1.2
1.3
111.0
157.6
iu/ml
0.23
11
92
8
48
1.68
0.79
2.1
1.7
—
—
—
0
0
19
132
1.47
0.78
8.2
3.8
—
—
—
0
0
12
183
0.64
0.75
2.0
2.0
—
—
—
0
0
9
55
1.66
0.74
3.0
3.2
0.6
0.6
nmol/l
—
9
47
5
25
2.02
0.73
1.4
1.4
—
—
—
0
0
7
40
1.77
0.71
1.1
1.3
—
—
—
0
0
35
438
0.77
0.71
1.5
1.5
—
—
—
0
0
5
28
1.80
0.66
1.4
1.1
—
—
—
0
0
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
8
127
0.62
0.65
1.0
1.2
—
—
—
0
0
5
29
1.74
0.64
1.2
1.2
—
—
—
0
0
263
2542
1.23
0.62
21.6
10.8
39.8
40.8
%
1.48
208
2216
8
52
1.55
0.60
2.0
1.5
—
—
—
0
0
8
53
1.52
0.59
1.1
1.1
—
—
—
0
0
8
53
1.52
0.59
1.1
1.1
—
—
—
0
0
9
61
1.49
0.54
2.2
2.1
—
—
—
0
0
9
65
1.40
0.51
1.4
1.2
—
—
—
0
0
7
45
1.57
0.49
2.4
1.9
—
—
—
0
0
16
210
0.75
0.48
1.6
1.6
—
—
—
0
0
65
577
1.16
0.46
4.2
3.1
0.0
0.0
estimate
0.50
26
236
19
149
1.29
0.43
1.0
1.2
0.3
2.7
u/ml
2.04
12
87
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
3.2
2.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
106.3
—
0
15
8
60
1.34
0.40
1.0
1.1
—
64.0
—
0
22
7
102
0.68
0.40
1.0
1.1
—
7.8
—
0
18
5
36
1.40
0.38
2.4
2.9
0.2
0.2
e9/l
—
5
25
6
44
1.37
0.34
1.7
1.1
—
—
—
0
0
20
241
0.82
0.33
1.3
1.5
—
—
—
0
0
7
53
1.33
0.31
2.1
1.5
—
—
—
0
0
18
217
0.82
0.30
1.2
1.4
—
—
—
0
0
8
109
0.73
0.29
1.5
1.3
5.9
3.6
ug/l
—
8
101
87
812
1.10
0.29
4.2
2.8
—
—
—
0
0
22
186
1.20
0.28
1.2
1.4
215.2
286.0
miu/ml
—
5
95
9
77
1.17
0.24
1.6
1.1
—
—
—
0
0
10
125
0.79
0.23
1.4
1.4
—
—
—
0
0
5
38
1.32
0.23
2.4
2.9
483.8
509.4
e6/l
—
5
26
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
15
176
0.84
0.20
1.5
1.5
—
—
—
0
0
19
218
0.86
0.20
1.2
1.4
—
—
—
0
0
19
218
0.86
0.20
1.2
1.4
—
—
—
0
0
53
495
1.09
0.18
3.0
2.4
—
—
—
0
0
8
68
1.18
0.16
1.1
2.3
—
—
—
0
0
9
79
1.14
0.15
1.6
1.1
—
—
—
0
0
27
293
0.91
0.13
1.4
1.4
—
—
—
0
0
34
318
1.08
0.11
1.5
1.2
4.1
5.6
u/ml
—
9
134
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
6
58
1.04
0.08
1.3
1.8
8.3
7.3
mmol/l
—
6
33
5
65
0.77
0.08
1.2
1.7
—
—
—
0
0
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
9
104
0.86
0.06
1.7
1.8
—
—
—
0
0
112
1103
1.02
0.05
2.2
1.9
—
—
—
0
0
21
218
0.96
0.02
1.2
1.4
—
—
—
0
0
13
127
1.02
0.00
1.3
1.8
6.1
3.0
mg/l
—
8
75
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
34.5
—
0
5
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
7
78
0.90
0.00
1.6
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
10.2
—
0
8
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
3.7
—
32.5
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_CHILDSOC – Social disorders starting during childhood or adolescence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).